GlassScriptPhysician profile
Sherfield Dawson III
NPI 1447212733
$7,058.30
in general payments reported to CMS, 2019-2025
8 companies · $2,487 in 2025
The $2,487 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $175 · 2021: $197 · 2022: $137 · 2023: $1,569 · 2024: $71.09 · 2025: $2,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,107 · Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,106.60 |
| Food and Beverage | $1,020.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $3,864.69 | 2019-2025 | Phasix Mesh, Echo Ps Positioning System |
| Zimmer Biomet Holdings, INC. | $1,343.59 | 2023 | Advantagerib, Ribfix Blu Advantage |
| C. R. Bard, INC. & Subsidiaries | $1,199.44 | 2019 | |
| Intuitive Surgical, INC. | $350.94 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $145.57 | 2023 | |
| Gilead Sciences, INC. | $63.15 | 2022 | |
| Medtronic, INC. | $47.42 | 2025 | Endoflip |
| Takeda Pharmaceuticals U.S.A., INC. | $43.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherfield Dawson III listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.